Visit us at booth #1015 to connect with our team and learn more about our Decipher Prostate and Bladder Genomic Classifiers. 

We are excited to announce 18+ abstracts, which will showcase data on Decipher Prostate, Decipher Bladder, and Decipher GRID. 

See the schedule below for dates and times to view these presentations. 

SATURDAY, APRIL 26, 2025 

 7:00 AM – 9:00 AM PT 

• Poster (IP02-22): Long non-coding RNAs identify a subgroup of patients with low-grade, non invasive bladder cancer with less favourable outcomes 

Presented by: Joep De Jong, M.D., Ph.D., Erasmus University Medical Center, Rotterdam, The Netherlands 

Marco Polo 701 

1:00 PM – 3:00 PM PT

• Poster (IP05-02): Risk Stratification using the Decipher 22-gene Genomic Classifier (GC) and Digital Pathology Artificial Intelligence (DPAI) in nearly 10,000 Localized Prostate Cancer Patients 

Presented by: Daniel Spratt, M.D., University Hospitals Seidman Cancer Center, Case Western Reserve University 

Casanova 501 

• Poster (IP05-05): Regional Prostate Cancer Transcriptomic Heterogeneity Observed in a Comparative Analysis with a National Cohort 

Presented by: Deepak Kapoor, M.D., Icahn School of Medicine at Mount Sinai

Casanova 501  

• Poster (IP05-14): Tumor Necrosis Factor Alpha Signaling in Decipher Testing Corresponds to Adverse Pathology at time of Radical Prostatectomy and Basal-Luminal Subtype 

Presented by: Conor Driscoll, M.D., Feinberg School of Medicine, Northwestern University 

Casanova 501

• Poster (IP05-17): Does PSA Predict Prostate Cancer Risk In The Age Of MRI And Genomics? 

Presented by: Ben Schurhamer, M.D., Hospital of the University of Pennsylvania, Penn Medicine 

Casanova 501

• Poster (IP05-27): Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy 

Presented by: Boris Hadaschik, M.D., University Hospital Essen, Germany 

Casanova 501

• Poster (IP05-36): Decipher GRID and PSMA-PET to Predict Extra-Prostatic Extension (EPE): Using Glycolysis Expression to Predict EPE 

Presented by: Daniel Sidhom, D.O., University of Indiana School of Medicine 

Casanova 501

3:30 PM – 5:30 PM PT

• Oral Presentation (PD12-06): 4:10 PM – 4:18 PM PT  

Gene Expression Signatures of Immune Infiltration Portend Differential Response to Sequential Intravesical Gemcitabine and Docetaxel versus Bacillus Calmette-Guerin in High-Risk Non-Muscle-Invasive Bladder Cancer 

Presented by: Vignesh Packiam, M.D., Rutgers Cancer Institute 

Galileo 1001 

• Moderated Poster (MP10-06): Validation of PAM50 and PSC Genomic Classifier Systems for Predicting Prostate Cancer Progression in Active Surveillance: Results from the Miami MAST Prospective Clinical Trial 

Presented by: Jonathan Ryan, Nova Southeastern University 

Casanova 503 

• Moderated Poster (MP10-08): Evaluating the association between the luminal proliferative subtype of prostate cancer with grade reclassification: Results from Canary Prostate Active Surveillance Study (PASS) 

Presented by: Meera Chappidi, M.D., University of Washington School of Medicine 

Casanova 503 

• Moderated Poster (MP10-10): Transcriptomic Examination of Grade Group 1 Prostate Cancer After Radical Prostatectomy 

Presented by: Nicole Handa, M.D., Feinberg School of Medicine, Northwestern University 

Casanova 503 

• Moderated Poster (MP10-13): Can Genomic classifiers in biopsy cores with Grade Group 1 cancer predict higher-grade disease elsewhere in the prostate? Results from the Miami Active Surveillance trial 

Presented by: Pedro Freitas, M.D., University of Miami 

Casanova 503 

SUNDAY, APRIL 27, 2025 

3:30 PM – 5:30 PM PT

• Moderated Poster (MP19-08): Decipher GRID Shows High Folate Receptor Beta (FR-b) Expression in Low PSMA Expression Prostate Cancer and Is Associated with Aggressive Clinical and Genomic Features 

Presented by: Daniel Sidhom, D.O., University of Indiana School of Medicine 

Casanova 503 

• Moderated Poster (MP19-11): The Penn Cohort: Can MRI “Decipher” your prostate risk? 

Presented by: Ben Schurhamer, M.D., University of Pennsylvania 

Casanova 503 

MONDAY, APRIL 28, 2025 

3:30 PM – 5:30 PM PT

• Moderated Poster (MP32-19): Characterizing the activity of inflammasome genes and their association with oncological outcomes in prostate cancer 

Presented by: Alireza Ghoreifi, M.D., Duke University 

Casanova 505 

• Poster (IP22-30) MRI as Risk Stratification in African American Men for High-risk Prostate Cancer: The Penn Cohort 

Presented by: Ben Schurhamer, M.D., Hospital of the University of Pennsylvania, Penn Medicine 

Casanova 501

• Poster (IP23-06): Pathologic Outcomes of Active Surveillance Candidates Electing Surgery in a Contemporary Series 

Presented by: Ronney Abaza, M.D., Central Ohio Urology Group, Columbus, Ohio 

Marco Polo 701 

TUESDAY, APRIL 29, 2025  

7:00 AM – 9:00 AM PT 

• Poster (IP25-20): Characterizing the activity of inflammasome genes and their association with oncological outcomes in prostate cancer 

Presented by: Gabriela Diaz, M.D., Department of Urology, Yale School of Medicine 

Marco Polo 701